ATE294856T1 - Lunasin peptide - Google Patents

Lunasin peptide

Info

Publication number
ATE294856T1
ATE294856T1 AT98949514T AT98949514T ATE294856T1 AT E294856 T1 ATE294856 T1 AT E294856T1 AT 98949514 T AT98949514 T AT 98949514T AT 98949514 T AT98949514 T AT 98949514T AT E294856 T1 ATE294856 T1 AT E294856T1
Authority
AT
Austria
Prior art keywords
peptide
cell
mitotic function
cells
target cell
Prior art date
Application number
AT98949514T
Other languages
English (en)
Inventor
Lumen Benito O De
Alfredo F Galvez
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE294856T1 publication Critical patent/ATE294856T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8262—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield involving plant development
    • C12N15/8263—Ablation; Apoptosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/908—Mechanical repair performed/surgical
    • Y10S977/911—Cancer cell destruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98949514T 1997-09-25 1998-09-25 Lunasin peptide ATE294856T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/938,675 US6107287A (en) 1997-09-25 1997-09-25 Lunasin peptides
PCT/US1998/020116 WO1999015642A1 (en) 1997-09-25 1998-09-25 Lunasin peptides

Publications (1)

Publication Number Publication Date
ATE294856T1 true ATE294856T1 (de) 2005-05-15

Family

ID=25471782

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98949514T ATE294856T1 (de) 1997-09-25 1998-09-25 Lunasin peptide

Country Status (9)

Country Link
US (3) US6107287A (de)
EP (1) EP1017798B1 (de)
JP (1) JP3818850B2 (de)
AT (1) ATE294856T1 (de)
AU (1) AU731631B2 (de)
CA (1) CA2303061C (de)
DE (1) DE69830066T2 (de)
ES (1) ES2242299T3 (de)
WO (1) WO1999015642A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391848B1 (en) * 1999-04-30 2002-05-21 The Regents Of The University Of California Soybean protein nutraceuticals
WO2001034808A2 (en) * 1999-11-12 2001-05-17 Filgen Biosciences, Inc. Method of large-scale production and method of testing of the biological activity of a substance from soybean
EP1268534A2 (de) * 2000-03-24 2003-01-02 Filgen Biosciences, Inc. Peptide, die nicht-acetylierten h3 und h4-histonen binden, zur krebstherapie
CN1741805A (zh) * 2001-07-18 2006-03-01 索莱有限责任公司 高蛋白质鲍曼－比尔克抑制剂浓缩物及其生产方法
AU2002365101A1 (en) * 2001-12-28 2003-07-24 Spectral Genomics, Inc. Articles of manufacture and methods for examining biochips using phase contrast optics
US7829277B2 (en) * 2004-03-01 2010-11-09 The Regents Of The University Of California Methods for identifying compounds that suppress chemically-induced carcinogenesis
US20100093767A1 (en) * 2004-12-03 2010-04-15 Takeda San Diego, Inc. Mitotic Kinase Inhibitors
US8598111B2 (en) * 2006-09-15 2013-12-03 Soy Labs, Llc Products and methods using soy peptides to lower total and LDL cholesterol levels
US7731995B2 (en) * 2006-09-16 2010-06-08 Alfredo Flores Galvez Methods for using soy peptides to inhibit H3 acetylation, reduce expression of HMG CoA reductase, and increase LDL receptor and Sp1 expression in a mammal
CA2664066C (en) 2006-09-16 2017-04-18 Soy Labs Llc Products and methods using soy peptides to lower total and ldl cholesterol levels
NZ555163A (en) 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
JP5158639B2 (ja) 2008-04-11 2013-03-06 独立行政法人農業生物資源研究所 植物の内胚乳に特異的に発現する遺伝子および該遺伝子のプロモーター、並びにそれらの利用
US8759613B1 (en) * 2009-10-26 2014-06-24 University Of Louisville Research Foundation, Inc. Method of producing a lunasin polypeptide in plants
WO2011060181A1 (en) * 2009-11-11 2011-05-19 University Of Louisville Research Foundation, Inc. Lunasin-containing complex and purification of lunasin from plants
WO2014145086A2 (en) 2013-03-15 2014-09-18 Galvez Alfredo Flores Products and methods using lunasin-enriched soy extract mixtures to reduce free fatty acid levels, increase leptin levels and increase adiponectin levels in plasma
CN108546289A (zh) * 2018-03-15 2018-09-18 中国农业科学院作物科学研究所 一种利用水稻真核表达系统制备lunasin多肽的方法及应用
US20220387551A1 (en) * 2019-10-20 2022-12-08 Sl Technology, Inc. Methods using sonication to increase bioactivity of soy peptides
KR102925317B1 (ko) * 2022-10-17 2026-02-11 주식회사 유씨아이테라퓨틱스 세포 내로 벡터의 도입 효율 증진용 조성물
WO2025220989A1 (ko) * 2024-04-16 2025-10-23 주식회사 유씨아이테라퓨틱스 자연살해세포의 증폭 및 형질 도입 효율 증진용 피더 세포

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5734022A (en) * 1990-08-01 1998-03-31 The Johns Hopkins University Antibodies to a novel mammalian protein associated with uncontrolled cell division
US5494806A (en) * 1991-04-05 1996-02-27 The General Hospital Corporation DNA and vectors encoding the parathyroid hormone receptor, transformed cells, and recombinant production of PTHR proteins and peptides
WO1995002698A1 (en) * 1993-07-12 1995-01-26 Life Technologies, Inc. Composition and methods for transfecting eukaryotic cells
US5594120A (en) * 1994-02-18 1997-01-14 Brigham And Women's Hospital, Inc. Integrin alpha subunit
US5850016A (en) * 1996-03-20 1998-12-15 Pioneer Hi-Bred International, Inc. Alteration of amino acid compositions in seeds
US5770422A (en) * 1996-07-08 1998-06-23 The Regents Of The University Of California Human telomerase
US6090577A (en) * 1997-05-22 2000-07-18 Incyte Pharmaceuticals, Inc. Disease associated acidic protein

Also Published As

Publication number Publication date
JP2001517434A (ja) 2001-10-09
US20030229038A1 (en) 2003-12-11
CA2303061A1 (en) 1999-04-01
DE69830066D1 (en) 2005-06-09
AU9582198A (en) 1999-04-12
US7375092B2 (en) 2008-05-20
ES2242299T3 (es) 2005-11-01
EP1017798B1 (de) 2005-05-04
US6107287A (en) 2000-08-22
AU731631B2 (en) 2001-04-05
WO1999015642A1 (en) 1999-04-01
DE69830066T2 (de) 2006-06-08
US6544956B1 (en) 2003-04-08
CA2303061C (en) 2007-11-27
EP1017798A1 (de) 2000-07-12
JP3818850B2 (ja) 2006-09-06

Similar Documents

Publication Publication Date Title
DE69830066D1 (en) Lunasin peptide
AP1678A (en) Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems.
DK0851868T3 (da) Höjniveau-ekspression af proteiner
US6114148C1 (en) High level expression of proteins
ATE282705T1 (de) Verbessertes barstar-gen
EP1159441B8 (de) Verabreichung von nukleinsäuren und proteinen an zellen
EP0653940A4 (de) Glialmitogene faktoren, ihre herstellung und verwendung.
ATE335078T1 (de) Überexpression von säugetier- und virusproteinen
ATE227739T1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
EP1336617A3 (de) Conotoxine, die an den Acetylcholinrezeptor Anbinden
WO2004061122A3 (en) Cell proliferation-related polypeptides and uses therefor
ATE272109T1 (de) Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden
DE69920747D1 (de) Methode zur herstellung von rekombinanten zellen
WO1995011309A3 (en) A novel nuclear mitotic phosphoprotein: mitosin
WO1999025878A3 (en) Methods for modulating and identifying cellular senescence
AU1172202A (en) Far red shifted fluorescent proteins
WO2005065348A3 (en) Transactivation system for mammalian cells
AU2003287115A1 (en) Fluorescent proteins from copepoda species and methods for using same
WO2002072872A3 (en) System for screening fatty acid transport inhibitors, methods of use and modulators identified thereby
AU2002211446A1 (en) 32144, a human fatty acid amide hydrolase and uses thereof
WO2002008417A1 (fr) Procede de production d'une proteine de recombinaison
WO2001040257A3 (en) Modified il-12 subunits and nucleic acids encoding them
DE69831242D1 (de) Erhöhte herstellung von sekretierten proteinen durch rekombinante hefezellen
BR9912106A (pt) Vetor de expressão de levedura recombinante, processo para fazer um polipeptìdeo ou proteìna desejados, e, célula de levedura transformada
Chumakov et al. Localization of VirB1 protein on the agrobacterial cell surface

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties